Phase II Study of Low-Dose Intravenous Decitabine in Patients Aged greater than 60 Years With Acute Myeloid Leukemia Who Are Not Eligible for Standard Induction Chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 25 Jan 2018
At a glance
- Drugs Decitabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 02 Sep 2011 New source identified and integrated (Germany Clinical Trials Registry).
- 27 Mar 2009 New trial record